{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Indonesia", "cinnamon", "curcumin", "mangosteen", "metabolic syndrome"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32435657", "DateRevised": {"Year": "2020", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "05", "Day": "06"}], "Language": ["eng"], "ELocationID": ["82", "10.3389/fcvm.2020.00082"], "Journal": {"ISSN": "2297-055X", "JournalIssue": {"Volume": "7", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in cardiovascular medicine", "ISOAbbreviation": "Front Cardiovasc Med"}, "ArticleTitle": "Selected Indonesian Medicinal Plants for the Management of Metabolic Syndrome: Molecular Basis and Recent Studies.", "Pagination": {"StartPage": "82", "MedlinePgn": "82"}, "Abstract": {"AbstractText": ["Increased prevalence of metabolic syndrome (MetS) in the world influences quality of health in all respective countries, including Indonesia. Data from Indonesian Family Life Survey reported in 2019 showed that the prevalence of MetS in Indonesia currently is 21.66%, estimated with the provincial incidence ranging up to 50%; additionally, the most common components of MetS discovered in Indonesia were poor high-density lipoprotein (HDL) cholesterol and hypertension. Management treatment of MetS involves a combination of lifestyle changes and pharmacological interventions to decrease cerebrovascular disease. Various natural substances have been shown to govern any cardiovascular or metabolic disorders through different mechanisms, such as triggering anti-inflammation, lipid profile correction, sensitization of insulin reception, or blood glucose control. In Indonesia, the utilization of natural compounds is part of the nation's culture. The community widely uses them; even though in general, their effectiveness and safety have not been thoroughly assessed by rigorous clinical trials. Scientific evidence suggested that cinnamon, mangosteen, and curcumin, as well as their derived components possess a broad spectrum of pharmacological activity. In this review, an enormous potential of cinnamon, mangosteen, and curcumin, which originated and are commonly used in Indonesia, could be treated against MetS, such as diabetes, hyperlipidemia, hypertension, and obesity. The findings suggested that cinnamon, mangosteen, curcumin and their derivatives may reflect areas of promise in the management of MetS."], "CopyrightInformation": "Copyright \u00a9 2020 Arozal, Louisa and Soetikno."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia."}], "LastName": "Arozal", "ForeName": "Wawaimuli", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia."}], "LastName": "Louisa", "ForeName": "Melva", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia."}], "LastName": "Soetikno", "ForeName": "Vivian", "Initials": "V"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Cardiovasc Med", "NlmUniqueID": "101653388", "ISSNLinking": "2297-055X"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. (2011) 9:48. 10.1186/1741-7015-9-48", "ArticleIdList": ["10.1186/1741-7015-9-48", "PMC3115896", "21542944"]}, {"Citation": "Ranasinghe P, Jayawardana R, Galappaththy P, Constantine GR, de Vas Gunawardana N, Katulanda P. Efficacy and safety of \u2018true\u2019 cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis. Diab Med. (2012) 29:1480\u201392. 10.1111/j.1464-5491.2012.03718.x", "ArticleIdList": ["10.1111/j.1464-5491.2012.03718.x", "22671971"]}, {"Citation": "Herningtyas EH, Ng TS. Prevalence and distribution of metabolic syndrome and its components among provinces and ethnic groups in Indonesia. BMC Public Health. (2019) 19:377. 10.1186/s12889-019-6711-7", "ArticleIdList": ["10.1186/s12889-019-6711-7", "PMC6448251", "30943932"]}, {"Citation": "Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. . The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. (2010) 56:1113\u201332. 10.1016/j.jacc.2010.05.034", "ArticleIdList": ["10.1016/j.jacc.2010.05.034", "20863953"]}, {"Citation": "Grundy SM. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nat Rev Drug Discov. (2006) 5:295\u2013309. 10.1038/nrd2005", "ArticleIdList": ["10.1038/nrd2005", "16582875"]}, {"Citation": "Pengpid S, Peltzer K. Utilization of traditional and complementary medicine in Indonesia: results of a national survey in 2014-15. Complement Ther Clin Pract. (2018) 33:156\u201363. 10.1016/j.ctcp.2018.10.006", "ArticleIdList": ["10.1016/j.ctcp.2018.10.006", "30396615"]}, {"Citation": "Woerdenbag HJ, Kayser O. Jamu: Indonesian traditional herbal medicine towards rational phytopharmacological use. J Herb Med. (2014) 4:51\u201373. 10.1016/j.hermed.2014.01.002", "ArticleIdList": ["10.1016/j.hermed.2014.01.002"]}, {"Citation": "Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. (2017) 11:215\u201325. 10.1177/1753944717711379", "ArticleIdList": ["10.1177/1753944717711379", "PMC5933580", "28639538"]}, {"Citation": "von Rintelen K, Arida E, H\u00e4user C. A review of biodiversity-related issues and challenges in megadiverse Indonesia and other Southeast Asian countries. Res Ideas Outcomes. (2017) 3:e20860 10.3897/rio.3.e20860", "ArticleIdList": ["10.3897/rio.3.e20860"]}, {"Citation": "Rao PV, Gan SH. Cinnamon: a multifaceted medicinal plant. Evid Based Complement Alternat Med. (2014) 2014:642932. 10.1155/2014/642942", "ArticleIdList": ["10.1155/2014/642942", "PMC4003790", "24817901"]}, {"Citation": "Kumar S, Kumari R, Mishra S. Pharmacological properties and their medicinal uses of Cinnamomum: a review. J Pharm Pharmacol. (2019) 71:1735\u201361. 10.1111/jphp.13173", "ArticleIdList": ["10.1111/jphp.13173", "31646653"]}, {"Citation": "Makimori RY, Endo EH, Makimori JW, Zanqueta EB, Ueda-Nakamura T, Leimann FV, et al. . Preparation, characterization and antidermatophytic activity of free- and microencapsulated cinnamon essential oil. J Mycol Med. 2020:100933. 10.1016/j.mycmed.2020.100933", "ArticleIdList": ["10.1016/j.mycmed.2020.100933", "32061515"]}, {"Citation": "Obolskiy D, Pischel I, Siriwatanametanon N, Heinrich M. Garcinia mangostana L.: a phytochemical and pharmacological review. Phytother Res. (2009) 23:1047\u201365. 10.1002/ptr.2730", "ArticleIdList": ["10.1002/ptr.2730", "19172667"]}, {"Citation": "Aizat WM, Jamil IN, Ahmad-Hashim FH, Noor NM. Recent updates on metabolite composition and medicinal benefits of mangosteen plant. Peer J. (2019) 7:e6324. 10.7717/peerj.6324", "ArticleIdList": ["10.7717/peerj.6324", "PMC6368837", "30755827"]}, {"Citation": "Wang MH, Zhang KJ, Gu QL, Bi XL, Wang JX. Pharmacology of mangostins and their derivatives: a comprehensive review. Chin J Nat Med. (2017) 15:81\u201393. 10.1016/S1875-5364(17)30024-9", "ArticleIdList": ["10.1016/S1875-5364(17)30024-9", "28284429"]}, {"Citation": "Gutierrez-Orozco F, Failla ML. Biological activities and bioavailability of mangosteen xanthones: a critical review of the current evidence. Nutrients. (2013) 5:3163\u201383. 10.3390/nu5083163", "ArticleIdList": ["10.3390/nu5083163", "PMC3775248", "23945675"]}, {"Citation": "Muchtaridi M, Suryani D, Qosim W, Saptarini N.\nQuantitative analysis of \u03b1-mangostin in mangosteen (Garcinia mangostana L.) Pericarp extract from four district of west java by HPLC method. Int J Pharm Pharm Sci. (2016) 8:232\u20136. Available online at: https://innovareacademics.in/journals/index.php/ijpps/article/view/12297/6296"}, {"Citation": "Nahar L, Sarker SD, Turner AB. A review on synthetic and natural steroid dimers: 1997-2006. Curr Med Chem. (2007) 14:1349\u201370. 10.2174/092986707780597880", "ArticleIdList": ["10.2174/092986707780597880", "17504217"]}, {"Citation": "Li R, Xiang C, Ye M, Li HF, Zhang X, Guo DA. Qualitative and quantitative analysis of curcuminoids in herbal medicines derived from Curcuma species. Food Chem. (2011) 126:1890\u20135. 10.1016/j.foodchem.2010.12.014", "ArticleIdList": ["10.1016/j.foodchem.2010.12.014", "25213973"]}, {"Citation": "Inoue K, Nomura C, Ito S, Nagatsu A, Hino T, Oka H. Purification of curcumin, demethoxycurcumin, and bisdemethoxycurcumin by high-speed countercurrent chromatography. J Agric Food Chem. (2008) 56:9328\u201336. 10.1021/jf801815n", "ArticleIdList": ["10.1021/jf801815n", "18826228"]}, {"Citation": "Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. (2007) 4:807\u201318. 10.1021/mp700113r", "ArticleIdList": ["10.1021/mp700113r", "17999464"]}, {"Citation": "Li JM, Li YC, Kong LD, Hu QH. Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats. Hepatology. (2010) 51:1555\u201366. 10.1002/hep.23524", "ArticleIdList": ["10.1002/hep.23524", "20222050"]}, {"Citation": "Maithilikarpagaselvi N, Sridhar MG, Swaminathan RP, Sripradha R, Badhe B. Curcumin inhibits hyperlipidemia and hepatic fat accumulation in high-fructose-fed male Wistar rats. Pharm Biol. (2016) 54:2857\u201363. 10.1080/13880209.2016.1187179", "ArticleIdList": ["10.1080/13880209.2016.1187179", "27241764"]}, {"Citation": "Cao H, Polansky MM, Anderson RA. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys. (2007) 459:214\u201322. 10.1016/j.abb.2006.12.034", "ArticleIdList": ["10.1016/j.abb.2006.12.034", "17316549"]}, {"Citation": "Sheng X, Zhang Y, Gong Z, Huang C, Zang YQ. Improved Insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors. PPAR Res. (2008) 2008:581348. 10.1155/2008/581348", "ArticleIdList": ["10.1155/2008/581348", "PMC2602825", "19096709"]}, {"Citation": "Chen L, Sun P, Wang T, Chen K, Jia Q, Wang H, et al. . Diverse mechanisms of antidiabetic effects of the different procyanidin oligomer types of two different cinnamon species on db/db mice. J Agric Food Chem. (2012) 60:9144\u201350. 10.1021/jf3024535", "ArticleIdList": ["10.1021/jf3024535", "22920511"]}, {"Citation": "Bandara T, Uluwaduge I, Jansz E. Bioactivity of cinnamon with special emphasis on diabetes mellitus: a review. Int J Food Sci Nutr. (2012) 63:380\u20136. 10.3109/09637486.2011.627849", "ArticleIdList": ["10.3109/09637486.2011.627849", "22007625"]}, {"Citation": "Medagama AB. The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials. Nutr J. (2015) 14:108. 10.1186/s12937-015-0098-9", "ArticleIdList": ["10.1186/s12937-015-0098-9", "PMC4609100", "26475130"]}, {"Citation": "Akilen R, Tsiami A, Devendra D, Robinson N. Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diab Med. (2010) 27:1159\u201367. 10.1111/j.1464-5491.2010.03079.x", "ArticleIdList": ["10.1111/j.1464-5491.2010.03079.x", "20854384"]}, {"Citation": "Manaf A, Tjandrawinata RR, Malinda D. Insulin sensitizer in prediabetes: a clinical study with DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa. Drug Des Dev Ther. (2016) 10:1279\u201389. 10.2147/DDDT.S97568", "ArticleIdList": ["10.2147/DDDT.S97568", "PMC4820281", "27099473"]}, {"Citation": "Talaei B, Amouzegar A, Sahranavard S, Hedayati M, Mirmiran P, Azizi F. Effects of cinnamon consumption on glycemic indicators, advanced glycation end products, and antioxidant status in type 2 diabetic patients. Nutrients. (2017) 9:991. 10.3390/nu9090991", "ArticleIdList": ["10.3390/nu9090991", "PMC5622751", "28885566"]}, {"Citation": "Taher M, Tg Zakaria TMFS, Susanti D, Zakaria ZA. Hypoglycemic activity of ethanolic extract of Garcinia mangostana Linn. in normoglycaemic and streptozotocin-induced diabetic rats. BMC Complement Altern Med. (2016) 16:135 10.1186/s12906-016-1118-9", "ArticleIdList": ["10.1186/s12906-016-1118-9", "PMC4875614", "27208974"]}, {"Citation": "Lee D, Kim YM, Jung K, Chin YW, Kang KS. Alpha-mangostin improves insulin secretion and protects INS-1 cells from streptozotocin-induced damage. Int J Mol Sci. (2018) 19:1484. 10.3390/ijms19051484", "ArticleIdList": ["10.3390/ijms19051484", "PMC5983655", "29772703"]}, {"Citation": "Ryu HW, Cho JK, Curtis-Long MJ, Yuk HJ, Kim YS, Jung S, et al. . \u03b1-Glucosidase inhibition and antihyperglycemic activity of prenylated xanthones from Garcinia mangostana. Phytochemistry. (2011) 72:2148\u201354. 10.1016/j.phytochem.2011.08.007", "ArticleIdList": ["10.1016/j.phytochem.2011.08.007", "21872893"]}, {"Citation": "Mekseepralard C, Areebambud C, Suksamrarn S, Jariyapongskul A. Effects of long-term alpha-mangostin supplementation on hyperglycemia and insulin resistance in type 2 diabetic rats induced by high fat diet and low dose streptozotocin. J Med Assoc Thai. (2015) 98:S23\u201330. Available online at: http://www.jmatonline.com/index.php/jmat/article/view/6887#", "ArticleIdList": ["27276829"]}, {"Citation": "Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. (2008) 51:216\u201326. 10.1007/s00125-007-0886-7", "ArticleIdList": ["10.1007/s00125-007-0886-7", "18087688"]}, {"Citation": "Al-Awar A, Kupai K, Veszelka M, Szucs G, Attieh Z, Murlasits Z, et al. . Experimental diabetes mellitus in different animal models. J Diab Res. (2016) 2016:9051426. 10.1155/2016/9051426", "ArticleIdList": ["10.1155/2016/9051426", "PMC4993915", "27595114"]}, {"Citation": "Panchal SK, Brown L. Rodent models for metabolic syndrome research. J Biomed Biotechnol. (2011) 2011:351982. 10.1155/2011/351982", "ArticleIdList": ["10.1155/2011/351982", "PMC3018657", "21253582"]}, {"Citation": "Wong SK, Chin KY, Suhaimi FH, Fairus A, Ima-Nirwana S. Animal models of metabolic syndrome: a review. Nutr Metab. (2016) 13:65. 10.1186/s12986-016-0123-9", "ArticleIdList": ["10.1186/s12986-016-0123-9", "PMC5050917", "27708685"]}, {"Citation": "Luo Y, Lei M. \u03b1-Mangostin protects against high-glucose induced apoptosis of human umbilical vein endothelial cells. Biosci Rep. (2017) 37:BSR20170779. 10.1042/BSR20170779", "ArticleIdList": ["10.1042/BSR20170779", "PMC5725610", "29054969"]}, {"Citation": "Tsai SY, Chung PC, Owaga EE, Tsai IJ, Wang PY, Tsai JI, et al. . Alpha-mangostin from mangosteen (Garcinia mangostana Linn.) pericarp extract reduces high fat-diet induced hepatic steatosis in rats by regulating mitochondria function and apoptosis. Nutr Metab. (2016) 13:88. 10.1186/s12986-016-0148-0", "ArticleIdList": ["10.1186/s12986-016-0148-0", "PMC5134003", "27980597"]}, {"Citation": "Luo Y, Fang Z, Ling Y, Luo W. LncRNA-H19 acts as a ceRNA to regulate HE4 expression by sponging miR-140 in human umbilical vein endothelial cells under hyperglycemia with or without \u03b1-Mangostin. Biomed Pharmacother. (2019) 118:109256 10.1016/j.biopha.2019.109256", "ArticleIdList": ["10.1016/j.biopha.2019.109256", "31362245"]}, {"Citation": "Tang W, Martin KA, Hwa J. Aldose reductase, oxidative stress, and diabetic mellitus. Front Pharmacol. (2012) 3:87. 10.3389/fphar.2012.00087", "ArticleIdList": ["10.3389/fphar.2012.00087", "PMC3348620", "22582044"]}, {"Citation": "Soda M, Endo S, Matsunaga T, Zhao HT, El-Kabbani O, Iinuma M, et al. . Inhibition of human aldose reductase-like protein (AKR1B10) by \u03b1-and \u03b3-mangostins, major components of pericarps of mangosteen. Biol Pharm Bull. (2012) 35:2075\u201380. 10.1248/bpb.b12-00538", "ArticleIdList": ["10.1248/bpb.b12-00538", "23123477"]}, {"Citation": "Bumrungpert A, Kalpravidh RW, Chitchumroonchokchai C, Chuang CC, West T, Kennedy A, et al. . Xanthones from mangosteen prevent lipopolysaccharide-mediated inflammation and insulin resistance in primary cultures of human adipocytes. J Nutr. (2009) 139:1185\u201391. 10.3945/jn.109.106617", "ArticleIdList": ["10.3945/jn.109.106617", "19403722"]}, {"Citation": "Jariyapongskul A, Areebambud C, Suksamrarn S, Mekseepralard C. Alpha-mangostin attenuation of hyperglycemia-induced ocular hypoperfusion and blood retinal barrier leakage in the early stage of type 2 diabetes rats. BioMed Res Int. (2015) 2015:785826. 10.1155/2015/785826", "ArticleIdList": ["10.1155/2015/785826", "PMC4407409", "25950001"]}, {"Citation": "Jariyapongskul A, Areebambud C, Hideyuki N. Microhemodynamic indices to evaluate the effectiveness of herbal medicine in diabetes: a comparison between alpha-mangostin and curcumin in the retina of type 2 diabetic rats. Clin Hemorheol Microcirc. (2018) 69:471\u201380. 10.3233/CH-170345", "ArticleIdList": ["10.3233/CH-170345", "29332034"]}, {"Citation": "Abdallah HM, El-Bassossy H, Mohamed GA, El-Halawany AM, Alshali KZ, Banjar ZM. Phenolics from Garcinia mangostana inhibit advanced glycation endproducts formation: effect on amadori products, cross-linked structures and protein thiols. Molecules. (2016) 21:251. 10.3390/molecules21020251", "ArticleIdList": ["10.3390/molecules21020251", "PMC6273600", "26907243"]}, {"Citation": "Liu T, Duan W, Nizigiyimana P, Gao L, Liao Z, Xu B, et al. Alpha-mangostin attenuates diabetic nephropathy in association with suppression of acid sphingomyelinase and endoplasmic reticulum stress. Biochem Biophys Res Comm. (2018) 496:394\u2013400. 10.1016/j.bbrc.2018.01.040", "ArticleIdList": ["10.1016/j.bbrc.2018.01.040", "29317203"]}, {"Citation": "Widowati W, Laksmitawati DR, Wargasetia TL, Afifah E, Amalia A, Arinta Y, et al. . Mangosteen peel extract (Garcinia mangostana L.) as protective agent in glucose-induced mesangial cell as in vitro model of diabetic glomerulosclerosis. Iran J Basic Med Sci. (2018) 21:972\u20137. 10.22038/IJBMS.2018.29349.7094", "ArticleIdList": ["10.22038/IJBMS.2018.29349.7094", "PMC6272065", "30524699"]}, {"Citation": "Jay U, Betsy S, Marilyn B, Vijay S. Evaluation of Mangosteen juice blend on biomarkers of inflammation in obese subjects: a pilot, dose finding study. Nutr J. (2009) 8:48 10.1186/1475-2891-8-48", "ArticleIdList": ["10.1186/1475-2891-8-48", "PMC2770545", "19843321"]}, {"Citation": "Stern J, Peerson J, Mishra A, Sadasiva Rao M, Rajeswari K. Efficacy and tolerability of a novel herbal formulation for weight management. Obesity. (2013) 21:921\u20137. 10.1002/oby.20211", "ArticleIdList": ["10.1002/oby.20211", "23784895"]}, {"Citation": "Watanabe M, Gangitano E, Francomano D, Addessi E, Toscano R, Costantini D, et al. . Mangosteen extract shows a potent insulin sensitizing effect in obese female patients: a prospective randomized controlled pilot study. Nutrients. (2018) 10:586. 10.3390/nu10050586", "ArticleIdList": ["10.3390/nu10050586", "PMC5986466", "29747432"]}, {"Citation": "Jiang CS, Liang LF, Guo YW. Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades. Acta Pharmacol Sin. (2012) 33:1217\u201345. 10.1038/aps.2012.90", "ArticleIdList": ["10.1038/aps.2012.90", "PMC4002712", "22941286"]}, {"Citation": "Arun N, Nalini N. Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr. (2002) 57:41\u201352. 10.1023/A:1013106527829", "ArticleIdList": ["10.1023/A:1013106527829", "11855620"]}, {"Citation": "Pari L, Murugan P. Influence of tetrahydrocurcumin on tail tendon collagen contents and its properties in rats with streptozotocin\u2013nicotinamide-induced type 2 diabetes. Fundam Clin Pharmacol. (2007) 21:665\u201371. 10.1111/j.1472-8206.2007.00542.x", "ArticleIdList": ["10.1111/j.1472-8206.2007.00542.x", "18034669"]}, {"Citation": "Peeyush KT, Gireesh G, Jobin M, Paulose C. Neuroprotective role of curcumin in the cerebellum of streptozotocin-induced diabetic rats. Life Sci. (2009) 85:704\u201310. 10.1016/j.lfs.2009.09.012", "ArticleIdList": ["10.1016/j.lfs.2009.09.012", "19804785"]}, {"Citation": "Soetikno V, Watanabe K, Sari FR, Harima M, Thandavarayan RA, Veeraveedu PT, et al. . Curcumin attenuates diabetic nephropathy by inhibiting PKC-\u03b1 and PKC-\u03b21 activity in streptozotocin-induced type I diabetic rats. Mol Nutr Food Res. (2011) 55:1655\u201365. 10.1002/mnfr.201100080", "ArticleIdList": ["10.1002/mnfr.201100080", "22045654"]}, {"Citation": "El-Azab MF, Attia FM, El-Mowafy AM. Novel role of curcumin combined with bone marrow transplantation in reversing experimental diabetes: effects on pancreatic islet regeneration, oxidative stress, and inflammatory cytokines. Eur J Pharmacol. (2011) 658:41\u20138. 10.1016/j.ejphar.2011.02.010", "ArticleIdList": ["10.1016/j.ejphar.2011.02.010", "21349269"]}, {"Citation": "Jain SK, Rains J, Croad J, Larson B, Jones K. Curcumin supplementation lowers TNF-\u03b1, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-\u03b1, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal. (2009) 11:241\u20139. 10.1089/ars.2008.2140", "ArticleIdList": ["10.1089/ars.2008.2140", "PMC2933148", "18976114"]}, {"Citation": "Gutierres VO, Assis RP, Arcaro CA, Oliveira JO, Lima TFO, Beretta ALRZ, et al. . Curcumin improves the effect of a reduced insulin dose on glycemic control and oxidative stress in streptozotocin-diabetic rats. Phytother Res. (2019) 33:976\u201388. 10.1002/ptr.6291", "ArticleIdList": ["10.1002/ptr.6291", "30656757"]}, {"Citation": "Gutierres VO, Pinheiro CM, Assis RP, Vendramini RC, Pepato MT, Brunetti IL. Curcumin-supplemented yoghurt improves physiological and biochemical markers of experimental diabetes. Br J Nutr. (2012) 108:440\u20138. 10.1017/S0007114511005769", "ArticleIdList": ["10.1017/S0007114511005769", "22067670"]}, {"Citation": "Seo K-I, Choi MS, Jung UJ, Kim HJ, Yeo J, Jeon SM, et al. . Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. Mol Nutr Food Res. (2008) 52:995\u20131004. 10.1002/mnfr.200700184", "ArticleIdList": ["10.1002/mnfr.200700184", "18398869"]}, {"Citation": "El-Moselhy MA, Taye A, Sharkawi SS, El-Sisi SFI, Ahmed AF. The antihyperglycemic effect of curcumin in a high fat diet fed rats. Role of TNF-\u03b1 and free fatty acids. Food Chem Toxicol. (2011) 49:1129\u201340. 10.1016/j.fct.2011.02.004", "ArticleIdList": ["10.1016/j.fct.2011.02.004", "21310207"]}, {"Citation": "Kaur G, Meena C. Amelioration of obesity, glucose intolerance, and oxidative stress in high-fat diet and low-dose streptozotocin-induced diabetic rats by combination consisting of \u201ccurcumin with piperine and quercetin\u201d. ISRN Pharmacol. (2012) 2012:957283 10.5402/2012/957283", "ArticleIdList": ["10.5402/2012/957283", "PMC3317057", "22474599"]}, {"Citation": "Na LX, Zhang YL, Li Y, Liu LY, Li R, Kong T, et al. . Curcumin improves insulin resistance in skeletal muscle of rats. Nutr Metab Cardiovasc Dis. (2011) 21:526\u201333. 10.1016/j.numecd.2009.11.009", "ArticleIdList": ["10.1016/j.numecd.2009.11.009", "20227862"]}, {"Citation": "Panahi Y, Khalili N, Sahebi E, Namazi S, Atkin SL, Majeed M, et al. . Curcuminoids plus piperine modulate adipokines in type 2 diabetes mellitus. Curr Clin Pharmacol. (2017) 12:253\u20138. 10.2174/1574884713666180104095641", "ArticleIdList": ["10.2174/1574884713666180104095641", "29299989"]}, {"Citation": "Panahi Y, Khalili N, Sahebi E, Namazi S, Simental-Mend\u00eda LE, Majeed M, et al. . Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial. Drug Res. (2018) 68:403\u20139. 10.1055/s-0044-101752", "ArticleIdList": ["10.1055/s-0044-101752", "29458218"]}, {"Citation": "Maric-Bilkan C. Obesity and diabetic kidney disease. Med Clin. (2013) 97:59\u201374. 10.1016/j.mcna.2012.10.010", "ArticleIdList": ["10.1016/j.mcna.2012.10.010", "PMC3539140", "23290730"]}, {"Citation": "Tikoo K, Meena R, Kabra D, Gaikwad A. Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy. Br J Pharmacol. (2008) 153:1225\u201331. 10.1038/sj.bjp.0707666", "ArticleIdList": ["10.1038/sj.bjp.0707666", "PMC2275435", "18204486"]}, {"Citation": "Sharma S, Kulkarni SK, Chopra K. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol. (2006) 33:940\u20135. 10.1111/j.1440-1681.2006.04468.x", "ArticleIdList": ["10.1111/j.1440-1681.2006.04468.x", "17002671"]}, {"Citation": "Ma J, Phillips L, Wang Y, Dai T, LaPage J, Natarajan R, et al. Curcumin activates the p38 MAPK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC. BMC Complement Altern Med. (2010) 10:1\u201317. 10.1186/1472-6882-10-67", "ArticleIdList": ["10.1186/1472-6882-10-67", "PMC2999583", "21073732"]}, {"Citation": "Khajehdehi P, Pakfetrat M, Javidnia K, Azad F, Malekmakan L, Nasab MH, et al. . Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-\u03b2 and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. Scand J Urol Nephrol. (2011) 45:365\u201370. 10.3109/00365599.2011.585622", "ArticleIdList": ["10.3109/00365599.2011.585622", "21627399"]}, {"Citation": "Na LX, Li Y, Pan HZ, Zhou XL, Sun DJ, Meng M, et al. . Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Mol Nutr Food Res. (2013) 57:1569\u201377. 10.1002/mnfr.201200131", "ArticleIdList": ["10.1002/mnfr.201200131", "22930403"]}, {"Citation": "Nyadjeu P, Dongmo A, Nguelefack TB, Kamanyi A. Antihypertensive and vasorelaxant effects of Cinnamomum zeylanicum stem bark aqueous extract in rats. J Compl Integr Med. (2011) 8:1\u201318. 10.2202/1553-3840.1490", "ArticleIdList": ["10.2202/1553-3840.1490", "22754922"]}, {"Citation": "Mousavi SM, Karimi E, Hajishafiee M, Milajerdi A, Amini MR, Esmaillzadeh A. Anti-hypertensive effects of cinnamon supplementation in adults: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. (2019) 16:1\u201311. 10.1080/10408398.2019.1678012", "ArticleIdList": ["10.1080/10408398.2019.1678012", "31617744"]}, {"Citation": "Saxena T, Ali AO, Saxena M. Pathophysiology of essential hypertension: an update. Expert Rev Cardiovasc Ther. (2018) 16:879\u201387. 10.1080/14779072.2018.1540301", "ArticleIdList": ["10.1080/14779072.2018.1540301", "30354851"]}, {"Citation": "Tep-Areenan P, Suksamrarn S. Mechanisms of vasorelaxation to gamma-mangostin in the rat aorta. J Med Assoc Thai. (2012) 95(Suppl. 12):S63\u20138. Available online at: http://www.jmatonline.com/index.php/jmat/article/view/2389", "ArticleIdList": ["23513467"]}, {"Citation": "Chitchumroonchokchai C, Riedl KM, Suksumrarn S, Clinton SK, Kinghorn AD, Failla ML. Xanthones in mangosteen juice are absorbed and partially conjugated by healthy adults. J Nutr. (2012) 142:675\u201380. 10.3945/jn.111.156992", "ArticleIdList": ["10.3945/jn.111.156992", "PMC3301988", "22399525"]}, {"Citation": "Hadi A, Pourmasoumi M, Ghaedi E, Sahebkar A. The effect of Curcumin/Turmeric on blood pressure modulation: a systematic review and meta-analysis. Pharmacol Res. (2019) 150:104505. 10.1016/j.phrs.2019.104505", "ArticleIdList": ["10.1016/j.phrs.2019.104505", "31647981"]}, {"Citation": "Siviero A, Gallo E, Maggini V, Gori L, Mugelli A, Firenzuoli F, et al. Curcumin, a golden spice with a low bioavailability. J Herb Med. (2015) 5:57\u201370. 10.1016/j.hermed.2015.03.001", "ArticleIdList": ["10.1016/j.hermed.2015.03.001"]}, {"Citation": "Collaboration PS. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. (2002) 360:1903\u201313. 10.1016/S0140-6736(02)11911-8", "ArticleIdList": ["10.1016/S0140-6736(02)11911-8", "12493255"]}, {"Citation": "Yao Y, Wang W, Li M, Ren H, Chen C, Wang J, et al. Curcumin exerts its anti-hypertensive effect by down-regulating the AT 1 receptor in vascular smooth muscle cells. Sci Rep. (2016) 6:1\u20138. 10.1038/srep25579", "ArticleIdList": ["10.1038/srep25579", "PMC4857140", "27146402"]}, {"Citation": "Nakmareong S, Kukongviriyapan U, Pakdeechote P, Kukongviriyapan V, Kongyingyoes B, Donpunha W, et al. . Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency. Hypertens Res. (2012) 35:418\u201325. 10.1038/hr.2011.180", "ArticleIdList": ["10.1038/hr.2011.180", "22072109"]}, {"Citation": "Xia J, Wang H, Zhang QM, Zheng Z, Han ZM. The therapeutic effect of curcumin in male albino rats and its putative mechanisms on cerebral microvascular flow. Brain Res. (2016) 1642:131\u20135. 10.1016/j.brainres.2016.03.022", "ArticleIdList": ["10.1016/j.brainres.2016.03.022", "27017961"]}, {"Citation": "Hodai H, Adibian M, Sohrab G. Effects of curcumin supplementation on BMI and blood pressure in patients with type 2 diabetes. Endocrine Abstracts. (2016) 43:OC51 10.1530/endoabs.43.OC51", "ArticleIdList": ["10.1530/endoabs.43.OC51"]}, {"Citation": "Jin S, Cho KH. Water extracts of cinnamon and clove exhibits potent inhibition of protein glycation and anti-atherosclerotic activity in vitro and in vivo hypolipidemic activity in zebrafish. Food Chemical Toxicol. (2011) 49:1521\u20139. 10.1016/j.fct.2011.03.043", "ArticleIdList": ["10.1016/j.fct.2011.03.043", "21443916"]}, {"Citation": "Nayak IN, Chinta R, Jetti R. Anti-atherosclerotic potential of aqueous extract of Cinnamomum zeylanicum bark against glucocorticoid induced atherosclerosis in wistar rats. J Clin Diagn Res. (2017) 11:FC19\u201323. 10.7860/JCDR/2017/23910.9864", "ArticleIdList": ["10.7860/JCDR/2017/23910.9864", "PMC5483700", "28658798"]}, {"Citation": "Kang H, Park SH, Yun JM, Nam TG, Kim YE, Kim DO, et al. . Effect of cinnamon water extract on monocyte-to-macrophage differentiation and scavenger receptor activity. BMC complement Altern Med. (2014) 14:90. 10.1186/1472-6882-14-90", "ArticleIdList": ["10.1186/1472-6882-14-90", "PMC3973967", "24602512"]}, {"Citation": "Yu SM, Wu TS, Teng CM. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Br J Pharmacol. (1994) 111:906\u201312. 10.1111/j.1476-5381.1994.tb14824.x", "ArticleIdList": ["10.1111/j.1476-5381.1994.tb14824.x", "PMC1910103", "8019768"]}, {"Citation": "Stocker R, Keaney JF, Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. (2004) 84:1381\u2013478. 10.1152/physrev.00047.2003", "ArticleIdList": ["10.1152/physrev.00047.2003", "15383655"]}, {"Citation": "Williams P, Ongsakul M, Proudfoot J, Croft K, Beilin L. Mangostin inhibits the oxidative modification of human low density lipoprotein. Free Rad Res. (1995) 23:175\u201384. 10.3109/10715769509064030", "ArticleIdList": ["10.3109/10715769509064030", "7581813"]}, {"Citation": "Mahabusarakam W, Proudfoot J, Taylor W, Croft K. Inhibition of lipoprotein oxidation by prenylated xanthones derived from mangostin. Free Rad Res. (2000) 33:643\u201359. 10.1080/10715760000301161", "ArticleIdList": ["10.1080/10715760000301161", "11200095"]}, {"Citation": "Shibata MA, Harada-Shiba M, Shibata E, Tosa H, Matoba Y, Hamaoka H, et al. . Crude \u03b1-Mangostin suppresses the development of atherosclerotic lesions in apoe-deficient mice by a possible M2 macrophage-mediated mechanism. Int J Mol Sci. (2019) 20:1722. 10.3390/ijms20071722", "ArticleIdList": ["10.3390/ijms20071722", "PMC6480575", "30959963"]}, {"Citation": "Wihastuti TA, Widodo MA, Heriansyah T, Sari NAK. Study of the inhibition effect of ethanolic extract of mangosteen pericarp on atherogenesis in hypercholesterolemic rat. Asian Pac J Trop Dis. (2015) 5:830\u20134. 10.1016/S2222-1808(15)60940-9", "ArticleIdList": ["10.1016/S2222-1808(15)60940-9"]}, {"Citation": "Wihastuti TA, Sargowo D, Tjokroprawiro A, Permatasari N, Widodo MA, Soeharto S. Vasa vasorum anti-angiogenesis through H2O2, HIF-1\u03b1, NF-\u03baB, and iNOS inhibition by mangosteen pericarp ethanolic extract (Garcinia mangostana Linn) in hypercholesterol-diet-given Rattus norvegicus Wistar strain. Vasc Health Risk Manag. (2014) 10:523\u201331. 10.2147/VHRM.S61736", "ArticleIdList": ["10.2147/VHRM.S61736", "PMC4149390", "25187725"]}, {"Citation": "Kudiganti V, Kodur RR, Kodur SR, Halemane M, Deep DK. Efficacy and tolerability of Meratrim for weight management: a randomized, double-blind, placebo-controlled study in healthy overweight human subjects. Lipids Health Dis. (2016) 15:136. 10.1186/s12944-016-0306-4", "ArticleIdList": ["10.1186/s12944-016-0306-4", "PMC4997756", "27558585"]}, {"Citation": "Brunzell JD. Clinical practice. Hypertriglyceridemia. New Engl J Med. (2007) 357:1009\u201317. 10.1056/NEJMcp070061", "ArticleIdList": ["10.1056/NEJMcp070061", "17804845"]}, {"Citation": "Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. (2003) 37:1202\u201319. 10.1053/jhep.2003.50193", "ArticleIdList": ["10.1053/jhep.2003.50193", "12717402"]}, {"Citation": "Shapiro H, Bruck R. Therapeutic potential of curcumin in non-alcoholic steatohepatitis. Nutr Res Rev. (2005) 18:212\u201321. 10.1079/NRR2005106", "ArticleIdList": ["10.1079/NRR2005106", "19079906"]}, {"Citation": "Jang EM, Choi MS, Jung UJ, Kim MJ, Kim HJ, Jeon SM, et al. . Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters. Metabolism. (2008) 57:1576\u201383. 10.1016/j.metabol.2008.06.014", "ArticleIdList": ["10.1016/j.metabol.2008.06.014", "18940397"]}, {"Citation": "Qin S, Huang L, Gong J, Shen S, Huang J, Ren H, et al. . Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials. Nutr J. (2017) 16:68. 10.1186/s12937-017-0293-y", "ArticleIdList": ["10.1186/s12937-017-0293-y", "PMC5637251", "29020971"]}, {"Citation": "Nishiyama T, Mae T, Kishida H, Tsukagawa M, Mimaki Y, Kuroda M, et al. . Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. J Agric Food Chem. (2005) 53:959\u201363. 10.1021/jf0483873", "ArticleIdList": ["10.1021/jf0483873", "15713005"]}, {"Citation": "Kang Q, Chen A. Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells. Br J Pharmacol. (2009) 157:1354\u201367. 10.1111/j.1476-5381.2009.00261.x", "ArticleIdList": ["10.1111/j.1476-5381.2009.00261.x", "PMC2765310", "19594758"]}, {"Citation": "Ferguson JJ, Stojanovski E, MacDonald-Wicks L, Garg ML. Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial. Metabolism. (2018) 82:22\u201335. 10.1016/j.metabol.2017.12.009", "ArticleIdList": ["10.1016/j.metabol.2017.12.009", "29291429"]}, {"Citation": "Kwan HY, Wu J, Su T, Chao XJ, Liu B, Fu X, et al. . Cinnamon induces browning in subcutaneous adipocytes. Sci Rep. (2017) 7:2447. 10.1038/s41598-017-02263-5", "ArticleIdList": ["10.1038/s41598-017-02263-5", "PMC5446408", "28550279"]}, {"Citation": "Jiang J, Emont MP, Jun H, Qiao X, Liao J, Kim DI, et al. . Cinnamaldehyde induces fat cell-autonomous thermogenesis and metabolic reprogramming. Metabolism. (2017) 77:58\u201364. 10.1016/j.metabol.2017.08.006", "ArticleIdList": ["10.1016/j.metabol.2017.08.006", "PMC5685898", "29046261"]}, {"Citation": "Van Hul M, Geurts L, Plovier H, Druart C, Everard A, St\u00e5hlman M, et al. . Reduced obesity, diabetes, and steatosis upon cinnamon and grape pomace are associated with changes in gut microbiota and markers of gut barrier. Am J Physiol Endocrinol Metab. (2018) 314:E334\u201352. 10.1152/ajpendo.00107.2017", "ArticleIdList": ["10.1152/ajpendo.00107.2017", "28874357"]}, {"Citation": "Liu Y, Cotillard A, Vatier C, Bastard JP, Fellahi S, St\u00e9vant M, et al. A dietary supplement containing cinnamon, chromium and carnosine decreases fasting plasma glucose and increases lean mass in overweight or obese pre-diabetic subjects: a randomized, placebo-controlled trial. PLoS ONE. (2015) 10:e0138646 10.1145/2818302", "ArticleIdList": ["10.1145/2818302", "PMC4583280", "26406981"]}, {"Citation": "Jain SG, Puri S, Misra A, Gulati S, Mani K. Effect of oral cinnamon intervention on metabolic profile and body composition of Asian Indians with metabolic syndrome: a randomized double-blind control trial. Lipids Health Dis. (2017) 16:113 10.1186/s12944-017-0504-8", "ArticleIdList": ["10.1186/s12944-017-0504-8", "PMC5469078", "28606084"]}, {"Citation": "Markey O, McClean CM, Medlow P, Davison GW, Trinick TR, Duly E, et al. . Effect of cinnamon on gastric emptying, arterial stiffness, postprandial lipemia, glycemia, and appetite responses to high-fat breakfast. Cardiovasc Diabetol. (2011) 10:78. 10.1186/1475-2840-10-78", "ArticleIdList": ["10.1186/1475-2840-10-78", "PMC3180260", "21899741"]}, {"Citation": "Quan X, Wang Y, Ma X, Liang Y, Tian W, Ma Q, et al. . \u03b1-Mangostin induces apoptosis and suppresses differentiation of 3T3-L1 cells via inhibiting fatty acid synthase. PLoS One. (2012) 7:e33376. 10.1371/journal.pone.0033376", "ArticleIdList": ["10.1371/journal.pone.0033376", "PMC3302861", "22428036"]}, {"Citation": "Taher M, Amiroudine M, Ali MZ, Zakaria T, Syafiq TMF, Susanti D, et al. . \u03b1-Mangostin improves glucose uptake and inhibits adipocytes differentiation in 3T3-L1 cells via PPAR\u03b3, GLUT4, and leptin expressions. Evid Based Complement Alternat Med. (2015) 2015:740238. 10.1155/2015/740238", "ArticleIdList": ["10.1155/2015/740238", "PMC4385643", "25873982"]}, {"Citation": "Petiwala SM, Li G, Ramaiya A, Kumar A, Gill RK, Saksena S, et al. . Pharmacokinetic characterization of mangosteen (Garcinia mangostana) fruit extract standardized to \u03b1-mangostin in C57BL/6 mice. Nutrition Res. (2014) 34:336\u201345. 10.1016/j.nutres.2014.03.002", "ArticleIdList": ["10.1016/j.nutres.2014.03.002", "PMC6298434", "24774070"]}, {"Citation": "Li L, Han AR, Kinghorn AD, Frye RF, Derendorf H, Butterweck V. Pharmacokinetic properties of pure xanthones in comparison to a mangosteen fruit extract in rats. Planta Med. (2013) 79:646\u201353. 10.1055/s-0032-1328543", "ArticleIdList": ["10.1055/s-0032-1328543", "23673465"]}, {"Citation": "Kim HM, Kim YM, Huh JH, Lee ES, Kwon MH, Lee BR, et al. \u03b1-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition CC chemokine receptor 2. PLoS ONE. (2017) 12:e0179204 10.1371/journal.pone.0179204", "ArticleIdList": ["10.1371/journal.pone.0179204", "PMC5466328", "28598982"]}, {"Citation": "Choi YH, Bae JK, Chae HS, Kim YM, Sreymom Y, Han L, et al. . \u03b1-Mangostin regulates hepatic steatosis and obesity through SirT1-AMPK and PPAR\u03b3 pathways in high-fat diet-induced obese mice. J Agric Food Chem. (2015) 63:8399\u2013406. 10.1021/acs.jafc.5b01637", "ArticleIdList": ["10.1021/acs.jafc.5b01637", "26368128"]}, {"Citation": "Ellulu MS, Patimah I, Khaza'ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. (2017) 13:851. 10.5114/aoms.2016.58928", "ArticleIdList": ["10.5114/aoms.2016.58928", "PMC5507106", "28721154"]}, {"Citation": "Castro A, Macedo-de la Concha L, Pantoja-Mel\u00e9ndez C. Low-grade inflammation and its relation to obesity and chronic degenerative diseases. Rev M\u00e9d Hosp Gen M\u00e9x. (2017) 80:101\u20135. 10.1016/j.hgmx.2016.06.011", "ArticleIdList": ["10.1016/j.hgmx.2016.06.011"]}, {"Citation": "Chen LG, Yang LL, Wang CC. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem Toxicol. (2008) 46:688\u201393. 10.1016/j.fct.2007.09.096", "ArticleIdList": ["10.1016/j.fct.2007.09.096", "18029076"]}, {"Citation": "Yin P, Zou W, Li J, Jin N, Gao Q, Liu F. Using high-throughput sequencing to explore the anti-inflammatory effects of \u03b1-mangostin. Sci Rep. (2019) 9:15626. 10.1038/s41598-019-52036-5", "ArticleIdList": ["10.1038/s41598-019-52036-5", "PMC6821923", "31666566"]}, {"Citation": "Bumrungpert A, Kalpravidh RW, Chuang CC, Overman A, Martinez K, Kennedy A, et al. . Xanthones from mangosteen inhibit inflammation in human macrophages and in human adipocytes exposed to macrophage-conditioned media. J Nutr. (2010) 140:842\u20137. 10.3945/jn.109.120022", "ArticleIdList": ["10.3945/jn.109.120022", "20181789"]}, {"Citation": "Shen Q, Chitchumroonchokchai C, Thomas JL, Gushchina LV, DiSilvestro D, Failla ML, et al. . Adipocyte reporter assays: application for identification of anti-inflammatory and antioxidant properties of mangosteen xanthones. Mol Nutr Food Res. (2014) 58:239\u201347. 10.1002/mnfr.201300181", "ArticleIdList": ["10.1002/mnfr.201300181", "PMC3946493", "24039005"]}, {"Citation": "Schug TT, Li X. Sirtuin 1 in lipid metabolism and obesity. Ann Med. (2011) 43:198\u2013211. 10.3109/07853890.2010.547211", "ArticleIdList": ["10.3109/07853890.2010.547211", "PMC3173813", "21345154"]}, {"Citation": "Gillum MP, Kotas ME, Erion DM, Kursawe R, Chatterjee P, Nead KT, et al. . SirT1 regulates adipose tissue inflammation. Diabetes. (2011) 60:3235\u201345. 10.2337/db11-0616", "ArticleIdList": ["10.2337/db11-0616", "PMC3219953", "22110092"]}, {"Citation": "Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A. Antagonistic crosstalk between NF-\u03baB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal. (2013) 25:1939\u201348. 10.1016/j.cellsig.2013.06.007", "ArticleIdList": ["10.1016/j.cellsig.2013.06.007", "23770291"]}, {"Citation": "Franceschelli S, Pesce M, Ferrone A, Patruno A, Pasqualone L, Carlucci G, et al. . A novel biological role of \u03b1-mangostin in modulating inflammatory response through the activation of SIRT-1 signaling pathway. J Cell Physiol. (2016) 231:2439\u201351. 10.1002/jcp.25348", "ArticleIdList": ["10.1002/jcp.25348", "26895796"]}, {"Citation": "Manna P, Jain SK. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metab Syndr Relat Disord. (2015) 13:423\u201344. 10.1089/met.2015.0095", "ArticleIdList": ["10.1089/met.2015.0095", "PMC4808277", "26569333"]}, {"Citation": "Xie Z, Sintara M, Chang T, Ou B. Functional beverage of Garcinia mangostana (mangosteen) enhances plasma antioxidant capacity in healthy adults. Food Sci Nutr. (2015) 3:32\u20138. 10.1002/fsn3.187", "ArticleIdList": ["10.1002/fsn3.187", "PMC4304560", "25649891"]}, {"Citation": "Oussaada SM, van Galen KA, Cooiman MI, Kleinendorst L, Hazebroek EJ, van Haelst MM, et al. . The pathogenesis of obesity. Metabolism. (2019) 92:26\u201336. 10.1016/j.metabol.2018.12.012", "ArticleIdList": ["10.1016/j.metabol.2018.12.012", "30639246"]}, {"Citation": "Gruzdeva O, Borodkina D, Uchasova E, Dyleva Y, Barbarash O. Leptin resistance: underlying mechanisms and diagnosis. Diabetes Metab Syndr Obes. (2019) 12:191\u20138. 10.2147/DMSO.S182406", "ArticleIdList": ["10.2147/DMSO.S182406", "PMC6354688", "30774404"]}, {"Citation": "Engin A. Diet-Induced obesity and the mechanism of leptin resistance. Adv Exp Med Biol. (2017) 960:381\u201397. 10.1007/978-3-319-48382-5_16", "ArticleIdList": ["10.1007/978-3-319-48382-5_16", "28585208"]}, {"Citation": "Abuzaid AS, Iskandar EY, Kurniati NF, Adnyana IK. Prevention of obesity and development of metabolic syndrome by mangosteen (Garcinia mangostana L.) pericarp ethanolic extract in male wistar rats fed with high-fat diet. Int J Pharm Pharmaceutic Sci. (2016) 8:1\u20137. 10.18311/jnr/2017/11051", "ArticleIdList": ["10.18311/jnr/2017/11051"]}, {"Citation": "Sun L, Ma L, Ma Y, Zhang F, Zhao C, Nie Y. Insights into the role of gut microbiota in obesity: pathogenesis, mechanisms, and therapeutic perspectives. Protein Cell. (2018) 9:397\u2013403. 10.1007/s13238-018-0546-3", "ArticleIdList": ["10.1007/s13238-018-0546-3", "PMC5960470", "29725936"]}, {"Citation": "Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. (2006) 444:1022\u20133. 10.1038/4441022a", "ArticleIdList": ["10.1038/4441022a", "17183309"]}, {"Citation": "Qin Y, Roberts JD, Grimm SA, Lih FB, Deterding LJ, Li R, et al. . An obesity-associated gut microbiome reprograms the intestinal epigenome and leads to altered colonic gene expression. Genome Biol. (2018) 19:7. 10.1186/s13059-018-1389-1", "ArticleIdList": ["10.1186/s13059-018-1389-1", "PMC5782396", "29361968"]}, {"Citation": "Gutierrez-Orozco F, Thomas-Ahner JM, Galley JD, Bailey MT, Clinton SK, Lesinski GB, et al. . Intestinal microbial dysbiosis and colonic epithelial cell hyperproliferation by dietary \u03b1-mangostin is independent of mouse strain. Nutrients. (2015) 7:764\u201384. 10.3390/nu7020764", "ArticleIdList": ["10.3390/nu7020764", "PMC4344559", "25621505"]}, {"Citation": "Sengupta K, Mishra AT, Rao MK, Sarma KV, Krishnaraju AV, Trimurtulu G. Efficacy and tolerability of a novel herbal formulation for weight management in obese subjects: a randomized double blind placebo controlled clinical study. Lipids Health Dis. (2012) 11:122. 10.1186/1476-511X-11-122", "ArticleIdList": ["10.1186/1476-511X-11-122", "PMC3492046", "22995673"]}, {"Citation": "He Y, Yue Y, Zheng X, Zhang K, Chen S, Du Z. Curcumin, inflammation, and chronic diseases: how are they linked? Molecules. (2015) 20:9183\u2013213. 10.3390/molecules20059183", "ArticleIdList": ["10.3390/molecules20059183", "PMC6272784", "26007179"]}, {"Citation": "Shao W, Yu Z, Chiang Y, Yang Y, Chai T, Foltz W, et al. . Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS ONE. (2012) 7:e28784. 10.1371/journal.pone.0028784", "ArticleIdList": ["10.1371/journal.pone.0028784", "PMC3253779", "22253696"]}, {"Citation": "Ejaz A, Wu D, Kwan P, Meydani M. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr. (2009) 139:919\u201325. 10.3945/jn.108.100966", "ArticleIdList": ["10.3945/jn.108.100966", "19297423"]}, {"Citation": "Chen HM, Li SJ, Chen HP, Wang QW, Li LS, Liu ZH. Obesity-related glomerulopathy in China: a case series of 90 patients. Am J of Kidney Dis. (2008) 52:58\u201365. 10.1053/j.ajkd.2008.02.303", "ArticleIdList": ["10.1053/j.ajkd.2008.02.303", "18423814"]}, {"Citation": "Miyazawa T, Nakagawa K, Kim SH, Thomas MJ, Paul L, Zingg J-M, et al. . Curcumin and piperine supplementation of obese mice under caloric restriction modulates body fat and interleukin-1\u03b2. Nutr Metab. (2018) 15:12. 10.1186/s12986-018-0250-6", "ArticleIdList": ["10.1186/s12986-018-0250-6", "PMC5801844", "29445415"]}, {"Citation": "Akbari M, Lankarani KB, Tabrizi R, Ghayour-Mobarhan M, Peymani P, Ferns G, et al. . The effects of curcumin on weight loss among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. (2019) 10:649. 10.3389/fphar.2019.00649", "ArticleIdList": ["10.3389/fphar.2019.00649", "PMC6582779", "31249528"]}, {"Citation": "van Duynhoven J, Vaughan EE, Jacobs DM, Kemperman RA, van Velzen EJJ, Gross G, et al. . Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci USA. (2011) 108(Suppl. 1):4531\u20138. 10.1073/pnas.1000098107", "ArticleIdList": ["10.1073/pnas.1000098107", "PMC3063601", "20615997"]}, {"Citation": "Burapan S, Kim M, Han J. Curcuminoid Demethylation as an alternative metabolism by human intestinal microbiota. J Agric Food Chem. (2017) 65:3305\u201310. 10.1021/acs.jafc.7b00943", "ArticleIdList": ["10.1021/acs.jafc.7b00943", "28401758"]}, {"Citation": "Zam W. Gut Microbiota as a prospective therapeutic target for curcumin: a review of mutual influence. J Nutr Metab. (2018) 2018:1367984. 10.1155/2018/1367984", "ArticleIdList": ["10.1155/2018/1367984", "PMC6311836", "30647970"]}, {"Citation": "Tanoue T, Umesaki Y, Honda K. Immune responses to gut microbiota-commensals and pathogens. Gut Microbes. (2010) 1:224\u201333. 10.4161/gmic.1.4.12613", "ArticleIdList": ["10.4161/gmic.1.4.12613", "PMC3023604", "21327029"]}, {"Citation": "Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. . Richness of human gut microbiome correlates with metabolic markers. Nature. (2013) 500:541\u20136. 10.1038/nature12506", "ArticleIdList": ["10.1038/nature12506", "23985870"]}, {"Citation": "Sonnenburg JL, B\u00e4ckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. (2016) 535:56\u201364. 10.1038/nature18846", "ArticleIdList": ["10.1038/nature18846", "PMC5991619", "27383980"]}, {"Citation": "Daniel H, Gholami AM, Berry D, Desmarchelier C, Hahne H, Loh G, et al. . High-fat diet alters gut microbiota physiology in mice. ISME J. (2014) 8:295\u2013308. 10.1038/ismej.2013.155", "ArticleIdList": ["10.1038/ismej.2013.155", "PMC3906816", "24030595"]}, {"Citation": "Shen L, Liu L, Ji HF. Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications. Food Nutr Res. (2017) 61:1361780. 10.1080/16546628.2017.1361780", "ArticleIdList": ["10.1080/16546628.2017.1361780", "PMC5553098", "28814952"]}, {"Citation": "Greiner AK, Papineni RVL, Umar S. Chemoprevention in gastrointestinal physiology and disease: natural products and microbiome. Am J Physiol Gastrointest Liver Physiol. (2014) 307:G1\u201315. 10.1152/ajpgi.00044.2014", "ArticleIdList": ["10.1152/ajpgi.00044.2014", "PMC4080166", "24789206"]}, {"Citation": "Bereswill S, Mu\u00f1oz M, Fischer A, Plickert R, Haag LM, Otto B, et al. . Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS ONE. (2010) 5:e15099. 10.1371/journal.pone.0015099", "ArticleIdList": ["10.1371/journal.pone.0015099", "PMC2997083", "21151942"]}, {"Citation": "Mohamed Sham Shihabudeen H, Hansi Priscilla D, Thirumurugan K. Cinnamon extract inhibits \u03b1-glucosidase activity and dampens postprandial glucose excursion in diabetic rats. Nutr Metab. (2011) 8:46. 10.1186/1743-7075-8-46", "ArticleIdList": ["10.1186/1743-7075-8-46", "PMC3155477", "21711570"]}, {"Citation": "Anand P, Murali KY, Tandon V, Murthy PS, Chandra R. Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats. Chem Biol Interact. (2010) 186:72\u201381. 10.1016/j.cbi.2010.03.044", "ArticleIdList": ["10.1016/j.cbi.2010.03.044", "20363216"]}, {"Citation": "Peng X, Cheng KW, Ma J, Chen B, Ho CT, Lo C, et al. . Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycation endproducts. J Agric Food Chem. (2008) 56:1907\u201311. 10.1021/jf073065v", "ArticleIdList": ["10.1021/jf073065v", "18284204"]}, {"Citation": "Zhang J, Wider B, Shang H, Li X, Ernst E. Quality of herbal medicines: challenges and solutions. Complement Ther Med. (2012) 20:100\u20136. 10.1016/j.ctim.2011.09.004", "ArticleIdList": ["10.1016/j.ctim.2011.09.004", "22305255"]}, {"Citation": "Yuan J, Dieter MP, Bucher JR, Jameson CW. Application of microencapsulation for toxicology studies. III. Bioavailability of microencapsulated cinnamaldehyde. Fundam Appl Toxicol. (1993) 20:83\u20137. 10.1093/toxsci/20.1.83", "ArticleIdList": ["10.1093/toxsci/20.1.83", "8432430"]}, {"Citation": "Lopresti AL. The problem of curcumin and its bioavailability: could its gastrointestinal influence contribute to its overall health-enhancing effects? Adv Nutr. (2018) 9:41\u201350. 10.1093/advances/nmx011", "ArticleIdList": ["10.1093/advances/nmx011", "PMC6333932", "29438458"]}, {"Citation": "Shen L, Ji HF. Bidirectional interactions between dietary curcumin and gut microbiota. Crit Rev Food Sci Nutr. (2019) 59:2896\u2013902. 10.1080/10408398.2018.1478388", "ArticleIdList": ["10.1080/10408398.2018.1478388", "29781709"]}, {"Citation": "An X, Bao Q, Di S, Zhao Y, Zhao S, Zhang H, et al. . The interaction between the gut Microbiota and herbal medicines. Biomed Pharmacother. (2019) 118:109252. 10.1016/j.biopha.2019.109252", "ArticleIdList": ["10.1016/j.biopha.2019.109252", "31545247"]}]}], "History": [{"Year": "2019", "Month": "12", "Day": "15"}, {"Year": "2020", "Month": "4", "Day": "16"}, {"Year": "2020", "Month": "5", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "22", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["32435657", "PMC7218133", "10.3389/fcvm.2020.00082"]}}]}